Quintiles, IMS Health unveil surprise megamerger
The world’s largest CRO, Quintiles, and healthcare consultancy IMS Health have unveiled a major megamerger deal in which they will merge in an all-stock, $9 billion merger of equals transaction.
The newly created company will be named “Quintiles IMS Holdings,” with the market cap of the joined companies over $17.6 billion, and the enterprise value over $23 billion.
The deal will merge the clinical applications of Quintiles’ business with IMS Health’s data gathering and analysis, giving the new company a collection of information for drugmakers.
